Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
10.59
-0.37 (-3.38%)
Jan 28, 2026, 10:53 AM EST - Market open
Trevi Therapeutics Employees
Trevi Therapeutics had 26 employees as of December 31, 2024. The number of employees increased by 1 or 4.00% compared to the previous year.
Employees
26
Change (1Y)
1
Growth (1Y)
4.00%
Revenue / Employee
n/a
Profits / Employee
-$1,763,769
Market Cap
1.36B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 26 | 1 | 4.00% |
| Dec 31, 2023 | 25 | 0 | - |
| Dec 31, 2022 | 25 | 1 | 4.17% |
| Dec 31, 2021 | 24 | 2 | 9.09% |
| Dec 31, 2020 | 22 | 5 | 29.41% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 645 |
| Pharming Group | 404 |
| Sana Biotechnology | 194 |
| Relay Therapeutics | 188 |
| AnaptysBio | 136 |
| Innoviva | 127 |
| DBV Technologies | 110 |
| Inventiva | 84 |
TRVI News
- 5 days ago - Trevi Therapeutics Announces Publication of Data from the Phase 2b IPF Chronic Cough Trial of nalbuphine ER in the Journal of the American Medical Association (JAMA) - PRNewsWire
- 20 days ago - Trevi Therapeutics Provides Strategic Updates Ahead of Annual LifeSci Partners Corporate Access Event Held During the J.P. Morgan Healthcare Conference - PRNewsWire
- 7 weeks ago - Trevi Therapeutics Announces Appointment of David Hastings as Chief Financial Officer - PRNewsWire
- 7 weeks ago - Trevi Therapeutics: "Buy" Rating For Haduvio Treating Chronic Cough In IPF And Beyond - Seeking Alpha
- 2 months ago - Trevi Therapeutics, Inc. (TRVI) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Trevi Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates - PRNewsWire
- 2 months ago - Trevi Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on November 13, 2025 - PRNewsWire
- 3 months ago - Trevi Therapeutics to Participate in Stifel 2025 Healthcare Conference - PRNewsWire